Author

Pierric Biber

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Marcel DeckertiD· 3 shared Sophie Tartare‐DeckertiD· 3 shared Alexandrine CarminatiiD· 2 shared Christophe A. J. GirardiD· 2 shared Frédéric Larbret· 2 shared Margaux LecacheuriD· 2 shared Marie IrondelleiD· 2 shared Mira Kahil· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Marcel DeckertORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway

Margaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, Mira Rabbaa, Océane Bouvet, Serena Diazzi, Pierric Biber, Christopher Rovera, Marie Irondelle, Frédéric Larbret, Virginie Prod’homme, Christophe A. J. Girard, Marcel Deckert, Sophie Tartare‐Deckert

This study shows that ECM stiffness influences dedifferentiated melanoma cells via DDR1/2 and YAP, affecting their behavior and drug resistance.

Oncogenesis · Jun 13, 2026Peer-reviewedCancer Biology

PSMD14 drives melanoma cell survival and MAPK inhibitor resistance through histone H2A deubiquitination

Michael Ohanna, Pierric Biber, Mira Kahil, Serena Diazzi, Lauren Lefevre, Frédéric Larbret, Robin Didier, Stéphane Audebert, Véronique Delmas, Lionel Larue, Sophie Tartare‐Deckert, Marcel Deckert

This study identifies PSMD14 as a key driver of melanoma survival and resistance to MAPK inhibitors by deubiquitinating histone H2A, altering chromatin state and gene expression.

bioRxiv · Mar 2, 2026 · PreprintCancer Biology

USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization

Pierric Biber, Alexandrine Carminati, Walaa Mohager, Mickaël Ohanna, Christophe A. J. Girard, Margaux Lecacheur, Mira Kahil, Océane Bouvet, Marie Irondelle, Stéphane Audebert, Mehdi Khaled, Sophie Tartare‐Deckert, Marcel Deckert

This study identifies USP9X as a mechanosensitive deubiquitinase that stabilizes YAP to enhance tumor cell invasiveness and drug resistance.

Cell Reports · Oct 1, 2025Peer-reviewedCancer Biology